PolyPid Ltd. POLY 深沪

已收盘 08-29 16:00:00 美东时间

39.82

0.000

0.00%

华盛通

立即下载

最高--
今开--
成交量 0股
最低 --
昨收 39.82
总市值 17.52亿
52周最高 40.82
市盈率 ^静 97.67
换手率 0.00%
52周最低 22.69
委比 0.00%
总股本 4399.39万
历史最高 81.23
量比 0
振幅 0.00%
历史最低 4.60
每手 1
风险率 0.00%

个股概要

财务分析

公司资料

分红派息

分时图
日k
周k
月k

相关新闻

PolyPid Appoints Brooke Story As Board Chairman, Effective Dec. 11

PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced the appointment of Brooke Story as Chairman of the Board of Directors,

2025-12-16 21:33
PolyPid Appoints Veteran MedTech Leader Brooke Story as Chairman of the Board of Directors

PolyPid Ltd. announced the appointment of Brooke Story as Chairman of its Board of Directors. With over 25 years of leadership experience in the MedTech industry, Story will enhance the company’s strategic, commercial, and transaction capabilities. Her expertise in surgical solutions and infection prevention will support PolyPid in advancing its lead product, D-PLEX₁₀₀, which is expected to submit its New Drug Application in early 2026. Story’s l...

2025-12-16 13:30
PolyPid Announces Positive FDA Pre-NDA Meeting Minutes for D-PLEX₁₀₀ Supporting NDA Submission

PolyPid Ltd. has received FDA support for rolling NDA submission of D-PLEX100, its lead product for preventing surgical site infections in colorectal surgeries. The FDA agreed the company's existing clinical data, including Phase 3 results, is adequate for submission. PolyPid plans to submit the first sections in early 2026, with the Breakthrough Therapy designation further validating its regulatory strategy.

2025-12-03 13:30
PolyPid to Participate in ROTH Capital Partners Virtual KOL Event on December 10, 2025

2025-11-25 13:30
PolyPid Advances D-PLEX₁₀₀ Towards FDA Submission and Commercial Readiness

PolyPid ( ($PYPD) ) has shared an announcement. PolyPid Ltd. announced its thir...

2025-11-12 20:56
PolyPid's D-PLEX₁₀₀ Wins BioTech Breakthrough Award for "Therapeutics Solution of the Year"

PolyPid's D-PLEX₁₀₀, designed to prevent surgical site infections (SSIs) via extended, localized antibiotic delivery, has been named "Therapeutics Solution of the Year" by BioTech Breakthrough. With Phase 3 results showing a 58% relative risk reduction in SSIs, the product, leveraging PolyPid's PLEX technology, delivers doxycycline for 30 days directly at the surgical site. Widespread SSIs remain a critical issue, causing extended hospital stays ...

2025-11-06 13:30
金色早报丨Polymarket将于11月底前重返美国代币化平台Securitize将通过SPAC上市

预测市场平台Polymarket即将向美国用户重新开放，并推出POLY代币和空投；Securitize将通过SPAC合并上市。加密货币市场整体跌幅明显。美国加密PAC筹资超能源行业，挪威加密申报激增。香港金管局计划将数字港元推广至个人用户。以太坊Fusaka硬分叉预计12月上线，提升可扩展性和安全性。 Mellon Prefix = synonym

2025-10-28 23:47
Inside The Speculation: Why Traders Think Polymarket's POLY Airdrop Could Be The Next Billion-Dollar Crypto Windfall

Can truth be tokenized?

2025-10-24 20:55
PolyPid Announces That Dr. Shmuel Sharoni Will Present Topline Phase 3 Shield II Trial Results For D-PLEX₁₀₀ At The 2025 American College Of Surgeons Clinical Congress In Chicago

PolyPid Ltd. (NASDAQ:PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that Dr. Shmuel Sharoni will present the topline results from the Company's

2025-09-30 20:50
PolyPid Completes Key GMP Inspection for D-PLEX100 Manufacturing Readiness

The latest update is out from PolyPid ( ($PYPD) ). PolyPid Ltd. announced on Se...

2025-09-16 20:59

派息除权日	每股总股息	派息日期
2020-02-19	0.15	2020-03-10
2019-11-19	0.15	2019-12-10
2019-08-19	0.15	2019-09-10
2019-05-17	0.15	2019-06-10
2019-02-19	0.15	2019-03-08
2018-11-19	0.15	2018-12-10
2018-08-17	0.15	2018-09-10
2018-05-17	0.15	2018-06-08
2018-02-16	0.15	2018-03-09
2017-11-17	0.15	2017-12-08
2017-08-16	0.15	2017-09-08
2017-05-17	0.15	2017-06-09
2017-02-16	0.15	2017-03-10
2016-11-16	0.15	2016-12-09
2016-08-17	0.15	2016-09-09
2016-05-18	0.15	2016-06-10
2016-02-17	0.15	2016-03-10
2015-11-18	0.15	2015-12-10
2015-08-18	0.15	2015-09-10
2015-05-18	0.15	2015-06-10
2015-02-18	0.15	2015-03-10
2014-11-18	0.15	2014-12-10
2014-08-18	0.15	2014-09-10
2014-05-16	0.15	2014-06-10
2014-02-18	0.10	2014-03-10
2013-11-18	0.10	2013-12-10
2013-08-16	0.10	2013-09-10
2013-05-16	0.10	2013-06-10
2013-02-15	0.10	2013-03-11
2012-11-16	0.10	2012-12-10
2012-08-16	0.10	2012-09-10
2012-05-16	0.10	2012-06-08
2012-02-15	0.05	2012-03-09
2011-11-16	0.05	2011-12-09
2011-08-17	0.05	2011-09-09
2011-05-18	0.05	2011-06-10
2011-02-17	0.05	2011-03-10
2010-11-17	0.05	2010-12-10
2010-08-18	0.05	2010-09-10
2010-05-18	0.05	2010-06-10
2010-02-17	0.05	2010-03-10
2009-11-18	0.05	2009-12-10
2009-08-18	0.05	2009-09-10
2009-05-18	0.05	2009-06-10
2009-02-06	0.05	2009-03-10
2008-11-06	0.05	2008-12-10
2008-08-06	0.05	2008-09-10
2008-05-07	0.05	2008-06-10
2008-02-07	0.05	2008-03-10
2007-11-07	0.05	2007-12-10
2007-08-08	0.05	2007-09-10
2007-05-16	0.05	2007-06-08
2007-02-07	0.05	2007-03-09
2006-11-08	0.05	2006-12-11
2006-08-08	0.05	2006-09-08
2006-05-17	0.05	2006-06-09
2006-02-08	0.05	2006-03-10
2005-11-10	0.05	2005-12-09
2005-08-10	0.05	2005-09-09
2005-05-06	0.05	2005-06-10
2005-02-09	0.05	2005-03-10
2004-11-09	0.05	2004-12-10
2004-08-11	0.05	2004-09-10

公司名称	Plantronics, Inc.
行业分类	Telecommunications Equipment
业务描述	Plantronics, Inc. engages in the design, manufacture, and distribution of headsets, voice, video, and content sharing solutions. It operates through the Products and Services segments. The Products segment includes the firm's headsets, voice, and video product lines. The Services segment includes maintenance support on hardware devices, as well as professional, managed and cloud services and solutions. The company was founded by Courtney Graham and Keith Larkin in 1961 and is headquartered in Santa Cruz, CA.

PolyPid Ltd. POLY 深 沪

39.82

个股概要

财务分析

公司资料

相关新闻

分红派息

相关新闻

公司简介

PolyPid Ltd. POLY 深沪